Top Buy
Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Sangamo Therapeutics Inc. | 13 | 16 | 1 | 4 | €0.79 | €4.10 | 417.030% |
PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €30.60 | €41.46 | 35.500% |
Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €47.38 | €56.86 | 20.013% |
Pfizer Inc. | 29 | 4 | 2 | 0 | €28.35 | €41.29 | 45.661% |
Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €13.80 | €25.58 | 85.348% |
Omeros Corp. | 2 | 4 | 0 | 0 | €4.88 | - | - |
Emergent Biosolutions Inc. | 4 | 3 | 1 | 0 | €12.87 | - | - |
Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €5.01 | €7.31 | 46.033% |
Immunic Inc. | 6 | 3 | 1 | 0 | €1.31 | €6.52 | 399.632% |
Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | €8.52 | €26.25 | 207.911% |
Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.36 | €3.64 | 167.971% |
Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €17.10 | €12.06 | -29.450% |
Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | €456.30 | €440.93 | -3.369% |
Arrowhead Pharmaceuticals Inc. | 21 | 2 | 5 | 0 | €26.67 | €54.98 | 106.153% |
Incyte Corp. | 13 | 2 | 1 | 1 | €63.20 | €77.67 | 22.898% |
TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.07 | €28.06 | 55.310% |
Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.88 | €18.37 | 875.877% |
Xencor Inc. | 14 | 1 | 0 | 0 | €19.60 | €31.70 | 61.717% |
Chromadex Corp | 10 | 1 | 0 | 0 | €2.94 | €5.55 | 88.898% |
Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.90 | €4.63 | 59.291% |
Personalis Inc | 8 | 1 | 0 | 0 | €3.19 | €3.26 | 2.467% |
Gilead Sciences Inc | 11 | 1 | 1 | 0 | €70.94 | €85.27 | 20.206% |
G1 Therapeutics | 21 | 1 | 0 | 0 | €3.64 | €10.54 | 189.813% |
Johnson & Johnson | 40 | 1 | 5 | 0 | €147.96 | €187.15 | 26.489% |
Stoke Therapeutics Inc | 17 | 1 | 2 | 0 | €14.60 | €20.55 | 40.725% |